BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31420025)

  • 21. Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn's disease: a ten-year hospital-based observational study in China.
    Wang H; Wu Y; Ye C; Liu Z; Wang X
    BMC Gastroenterol; 2021 Oct; 21(1):376. PubMed ID: 34649523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study.
    Chun J; Im JP; Kim JW; Lee KL; Choi CH; Kim H; Cheon JH; Ye BD; Kim YH; Kim YS; Jeen YT; Han DS; Kim WH; Kim JS
    Gut Liver; 2018 Sep; 12(5):544-554. PubMed ID: 30037171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015.
    Wewer MD; Zhao M; Nordholm-Carstensen A; Weimers P; Seidelin JB; Burisch J
    J Crohns Colitis; 2021 Jan; 15(1):5-13. PubMed ID: 32582937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile of pediatric Crohn's disease in Belgium.
    De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
    J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.
    Niewiadomski O; Studd C; Hair C; Wilson J; Ding NS; Heerasing N; Ting A; McNeill J; Knight R; Santamaria J; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Popp B; Connell W; Desmond P; Bell S
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.
    de Barros KSC; Flores C; Harlacher L; Francesconi CFM
    Dig Dis Sci; 2017 Sep; 62(9):2481-2488. PubMed ID: 28748409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.
    Göttgens KW; Jeuring SF; Sturkenboom R; Romberg-Camps MJ; Oostenbrug LE; Jonkers DM; Stassen LP; Masclee AA; Pierik MJ; Breukink SO
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):595-601. PubMed ID: 28350751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
    Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
    Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience.
    Allocca M; Bonifacio C; Fiorino G; Spinelli A; Furfaro F; Balzarini L; Bonovas S; Danese S
    Dig Liver Dis; 2017 Aug; 49(8):872-877. PubMed ID: 28416240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease.
    Gao X; Yang RP; Chen MH; Xiao YL; He Y; Chen BL; Hu PJ
    Scand J Gastroenterol; 2012 Oct; 47(10):1181-91. PubMed ID: 22845663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.
    Burisch J; Bergemalm D; Halfvarson J; Domislovic V; Krznaric Z; Goldis A; Dahlerup JF; Oksanen P; Collin P; de Castro L; Hernandez V; Turcan S; Belousova E; D'Incà R; Sartini A; Valpiani D; Giannotta M; Misra R; Arebi N; Duricova D; Bortlik M; Gatt K; Ellul P; Pedersen N; Kjeldsen J; Andersen KW; Andersen V; Katsanos KH; Christodoulou DK; Sebastian S; Barros L; Magro F; Midjord JM; Nielsen KR; Salupere R; Kievit HA; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Kaimakliotis IP; Schwartz D; Odes S; Lakatos L; Lakatos PL; Langholz E; Munkholm P;
    United European Gastroenterol J; 2020 Oct; 8(8):949-960. PubMed ID: 32715989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with perianal Crohn's fistulas experience delays in accessing anti-TNF therapy due to slow recognition, diagnosis and integration of specialist services: lessons learned from three referral centres.
    Lee MJ; Freer C; Adegbola S; Elkady S; Parkes M; Hart A; Fearnhead NS; Lobo AJ; Brown SR
    Colorectal Dis; 2018 Sep; 20(9):797-803. PubMed ID: 29569419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn's Disease.
    Kim ES; Kim SK; Jang BI; Kim KO; Kim EY; Lee YJ; Lee HS; Kwak SG;
    Dig Dis Sci; 2018 Sep; 63(9):2220-2230. PubMed ID: 29779084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and long-term prognosis of elderly-onset Crohn's disease.
    Song EM; Kim N; Lee SH; Chang K; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    Scand J Gastroenterol; 2018 Apr; 53(4):417-425. PubMed ID: 29457917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.
    El-Gazzaz G; Hull T; Church JM
    Colorectal Dis; 2012 Oct; 14(10):1217-23. PubMed ID: 22251452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the outcome of fistulising Crohn's disease.
    Molendijk I; Peeters KC; Baeten CI; Veenendaal RA; van der Meulen-de Jong AE
    Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):505-18. PubMed ID: 24913389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease.
    Keljo DJ; Markowitz J; Langton C; Lerer T; Bousvaros A; Carvalho R; Crandall W; Evans J; Griffiths A; Kay M; Kugathasan S; LeLeiko N; Mack D; Mamula P; Moyer MS; Oliva-Hemker M; Otley A; Pfefferkorn M; Rosh J; Hyams JS
    Inflamm Bowel Dis; 2009 Mar; 15(3):383-7. PubMed ID: 19023863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical characteristics and risk factors of refractory Crohn's disease].
    Xu P; He Y; Chen B; Mao R; Tang R; Li M; Chen F; Wu Y; Zeng Z; Chen M
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(38):2982-7. PubMed ID: 25547699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.